David L. Moyes

6.8k total citations
85 papers, 4.2k citations indexed

About

David L. Moyes is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, David L. Moyes has authored 85 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 29 papers in Epidemiology and 22 papers in Molecular Biology. Recurrent topics in David L. Moyes's work include Antifungal resistance and susceptibility (36 papers), Fungal Infections and Studies (25 papers) and Gut microbiota and health (17 papers). David L. Moyes is often cited by papers focused on Antifungal resistance and susceptibility (36 papers), Fungal Infections and Studies (25 papers) and Gut microbiota and health (17 papers). David L. Moyes collaborates with scholars based in United Kingdom, United States and Germany. David L. Moyes's co-authors include Julian R. Naglik, Jonathan P. Richardson, Bernhard Hube, Celia Murciano, Patrick J Venables, Manohursingh Runglall, Ayesha Islam, Jemima Ho, Selvam Thavaraj and Saeed Shoaie and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

David L. Moyes

82 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Moyes United Kingdom 37 2.1k 1.6k 1.1k 788 511 85 4.2k
Paul M. Sullam United States 46 2.3k 1.1× 2.1k 1.3× 1.9k 1.8× 540 0.7× 695 1.4× 106 5.7k
Yutaka Terao Japan 36 1.1k 0.5× 788 0.5× 1.0k 0.9× 498 0.6× 359 0.7× 129 3.5k
Richard D. Diamond United States 39 3.1k 1.5× 2.6k 1.7× 1.3k 1.2× 1.1k 1.4× 977 1.9× 77 5.7k
José Pontón Spain 37 3.2k 1.5× 2.3k 1.5× 781 0.7× 194 0.2× 230 0.5× 162 4.4k
Teruo Kirikae Japan 37 1.3k 0.6× 807 0.5× 1.5k 1.4× 1.1k 1.4× 439 0.9× 191 4.3k
Julia R. Köhler United States 26 3.3k 1.6× 2.3k 1.5× 2.2k 2.1× 477 0.6× 193 0.4× 63 5.3k
Mark S. Gresnigt Netherlands 34 1.7k 0.8× 1.6k 1.0× 1.2k 1.1× 1.4k 1.8× 203 0.4× 76 4.2k
John K. McCormick Canada 37 2.2k 1.1× 839 0.5× 1.9k 1.8× 1.4k 1.8× 545 1.1× 99 5.5k
Sing Sing Way United States 45 1.1k 0.5× 1.2k 0.8× 1.3k 1.2× 4.3k 5.5× 208 0.4× 119 7.2k
Boualem Sendid France 41 2.7k 1.3× 2.8k 1.8× 1.6k 1.5× 768 1.0× 120 0.2× 151 5.6k

Countries citing papers authored by David L. Moyes

Since Specialization
Citations

This map shows the geographic impact of David L. Moyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Moyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Moyes more than expected).

Fields of papers citing papers by David L. Moyes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Moyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Moyes. The network helps show where David L. Moyes may publish in the future.

Co-authorship network of co-authors of David L. Moyes

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Moyes. A scholar is included among the top collaborators of David L. Moyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Moyes. David L. Moyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joseph, Susan, et al.. (2025). Apical periodontitis microbiome association with salivary and serum inflammatory burden. International Endodontic Journal. 58(3). 504–515. 3 indexed citations
2.
Merrick, Blair, Elizabeth Allen, Karen Bisnauthsing, et al.. (2025). Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial. Journal of Infection. 91(1). 106504–106504. 3 indexed citations
3.
Dickenson, Ruth E., et al.. (2024). EGR1 regulates oral epithelial cell responses to Candida albicans via the EGFR- ERK1/2 pathway. Virulence. 15(1). 2435374–2435374.
4.
Bertuzzi, Margherita, et al.. (2023). Aspergillus fumigatus Drives Tissue Damage via Iterative Assaults upon Mucosal Integrity and Immune Homeostasis. Infection and Immunity. 91(2). e0033322–e0033322. 7 indexed citations
5.
Merrick, Blair, Chrysi Sergaki, Lindsey Edwards, et al.. (2023). Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT). Infectious Disease Reports. 15(3). 238–254. 14 indexed citations
6.
Zhang, Yuchen, Emily Ming‐Chieh Lu, David L. Moyes, & Sadia Niazi. (2023). Impact of Peri-Implant Inflammation on Metabolic Syndrome Factors: A Systematic Review. Applied Sciences. 13(21). 11747–11747. 1 indexed citations
7.
Lee, Sunjae, Aize Pellón, Jens Nielsen, et al.. (2022). Integrative functional analysis uncovers metabolic differences between Candida species. Communications Biology. 5(1). 1013–1013. 9 indexed citations
8.
Richardson, Jonathan P., Nessim Kichik, Sejeong Lee, et al.. (2022). Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins. mBio. 13(1). e0351021–e0351021. 47 indexed citations
9.
Griffiths, James S., Bianca M. Coleman, Mary Green, et al.. (2022). The Candida albicans toxin candidalysin mediates distinct epithelial inflammatory responses through p38 and EGFR-ERK pathways. Science Signaling. 15(728). eabj6915–eabj6915. 35 indexed citations
10.
Ponde, Nicole O., Jemima Ho, Jonathan P. Richardson, et al.. (2022). Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin. Journal of Biological Chemistry. 298(10). 102419–102419. 13 indexed citations
11.
Moyes, David L., et al.. (2022). The impact of apical periodontitis, non‐surgical root canal retreatment and periapical surgery on serum inflammatory biomarkers. International Endodontic Journal. 55(9). 923–937. 32 indexed citations
12.
Bidkhori, Gholamreza, Sunjae Lee, Abdellah Tebani, et al.. (2022). Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders. iScience. 25(7). 104513–104513. 38 indexed citations
13.
Blagojevic, Mariana, Giorgio Camilli, Michelle E. Maxson, et al.. (2021). Candidalysin triggers epithelial cellular stresses that induce necrotic death. Cellular Microbiology. 23(10). e13371–e13371. 36 indexed citations
14.
Bidkhori, Gholamreza, et al.. (2020). Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions. Microorganisms. 8(9). 1381–1381. 14 indexed citations
15.
Richardson, Jonathan P., Selene Mogavero, David L. Moyes, et al.. (2018). Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence. mBio. 9(1). 72 indexed citations
16.
Richardson, Jonathan P., David L. Moyes, Jemima Ho, & Julian R. Naglik. (2018). Candida innate immunity at the mucosa. Seminars in Cell and Developmental Biology. 89. 58–70. 55 indexed citations
17.
Verma, Akash, Nicole O. Ponde, Felix E.Y. Aggor, et al.. (2018). IL-36 and IL-1/IL-17 Drive Immunity to Oral Candidiasis via Parallel Mechanisms. The Journal of Immunology. 201(2). 627–634. 71 indexed citations
18.
Richardson, Jonathan P., Hubertine M. E. Willems, David L. Moyes, et al.. (2017). Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa. Infection and Immunity. 86(2). 137 indexed citations
19.
Moyes, David L., Manohursingh Runglall, Celia Murciano, Stephen Challacombe, & Julian R. Naglik. (2010). Epithelial cell discriminates between commensal and pathogenic Candida albicans via MAPK signaling independently of Dectin1, TLR2 or TLR4. Immunology. 131. 166–166. 1 indexed citations
20.
Moyes, David L., An Goris, Maria Ban, et al.. (2008). HERV-K113 Is Not Associated with Multiple Sclerosis in a Large Family-Based Study. AIDS Research and Human Retroviruses. 24(3). 363–365. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul M. Sullam Breakdown of academic impact, for papers by Yutaka Terao Breakdown of academic impact, for papers by Richard D. Diamond Breakdown of academic impact, for papers by José Pontón Breakdown of academic impact, for papers by Teruo Kirikae Breakdown of academic impact, for papers by Julia R. Köhler Breakdown of academic impact, for papers by Mark S. Gresnigt Breakdown of academic impact, for papers by John K. McCormick Breakdown of academic impact, for papers by Sing Sing Way Breakdown of academic impact, for papers by Boualem Sendid
Rankless by CCL
2026